Pediatric Post-Acute Sequelae of SARS-CoV-2 Infection.

Jason, Leonard A, Johnson, Madeline, Torres, Chelsea · Fatigue : biomedicine, health & behavior · 2023 · DOI

Quick Summary

This study compared young people recovering from long COVID (PASC) with young people who have ME/CFS to understand how their symptoms differ. Researchers asked 19 parents about their child's symptoms during initial COVID infection and again later, then compared these to 19 young people with ME/CFS. Most PASC symptoms improved over time, but fatigue and sleep problems stayed high—similar to what ME/CFS patients experience.

Why It Matters

This research helps clarify how long COVID presentations in youth overlap with and diverge from ME/CFS, supporting better diagnostic distinctions and tailored treatment approaches. Understanding symptom persistence patterns—especially fatigue and PEM—provides evidence that can improve clinical recognition and management of both conditions in pediatric populations.

Observed Findings

Significant reductions in immune, neuroendocrine, pain, and COVID-specific symptoms from acute infection to current timepoint in PASC group
Fatigue remained persistently elevated in both PASC and ME/CFS groups despite other symptom improvements
Sleep disturbances and post-exertional malaise symptoms persisted at high levels in PASC participants
ME/CFS participants showed worse overall symptomatology than PASC participants, with particularly severe neurocognitive symptoms
Symptom improvement trajectory differed between PASC and ME/CFS groups

Inferred Conclusions

Most PASC symptoms improve over time, but fatigue and PEM represent core persistent symptoms requiring targeted clinical attention
Youth with ME/CFS experience greater symptom burden overall compared to those with PASC, suggesting distinct disease severity or pathophysiology
Diagnostic and treatment approaches for youth PASC should account for symptoms that persist despite general recovery trends
Fatigue and PEM domains may warrant special focus in pediatric long COVID management strategies

Remaining Questions

What predicts which symptoms persist versus resolve in pediatric PASC, and are there biomarkers that identify high-risk groups?
What are the underlying biological mechanisms explaining why ME/CFS produces more severe overall symptomatology than PASC?
How do symptom trajectories differ between PASC and ME/CFS over longer follow-up periods (>1-2 years)?
Are there specific therapeutic interventions that can effectively address persistent fatigue and PEM in pediatric PASC?

What This Study Does Not Prove

This study does not establish causation or biological mechanisms underlying symptom persistence. The small sample size (n=19 per group) and reliance on parental questionnaire recall without objective clinical assessment limit generalizability. Cross-sectional design means we cannot determine long-term recovery trajectories or identify predictors of symptom resolution.

Topics

Sleep Dysfunction Post-Exertional Malaise

Metadata

DOI: 10.1080/21641846.2022.2162764
PMID: 38044956
Review status: Machine draft
Evidence level: Single-study or moderate support from human research
Last updated: 7 April 2026